Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, announced today that Simon Allport, aged 54, has been appointed to the Board as an independent non-executive Director.
Simon has 32 years’ experience in the professional services industry, first making partner at Arthur Andersen and rising to managing partner for the North of England and Scotland at Ernst & Young. He retired from Ernst & Young in 2017 and has since taken a small number of non-executive and consultancy roles.
Simon joins the Audit Committee with immediate effect.
The Board now comprises:
· Dan Wright (Executive Chairman)
· Gareth Jenkins (Chief Executive Officer)
· Steve Townsley (Chief Financial Officer)
· Joanne Lake (Independent Non-Executive Director)
· Euan Hamilton (Independent Non-Executive Director)
· Simon Allport (Independent Non-Executive Director)
Dan Wright, Executive Chairman of Accrol Group Holdings plc, said:
“Simon’s appointment increases the capabilities and calibre of an already much strengthened Board. The depth of his commercial knowledge and experience, combined with his clear thinking and direct approach, will be stimulating and valuable, as we accelerate the turnaround process in H2 and begin to explore the strategic growth options for the Group. On behalf of everyone at Accrol, I welcome Simon to the Board.”
Information on Simon required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:
Simon Allport is currently a director of the following companies:
· Fitzallan Limited
· The Enterprise Fund Limited
· Etale Limited
Simon is also a member of an independent advisory committee for Tosca Debt Capital LLP.
In addition, Simon was a partner in the following limited liability partnerships in the past five years:
· Ernst & Young Europe LLP
· Ernst & Young LLP
Simon has no interests in the share capital of Accrol Group Holdings plc.
